Authors:
Chi, JD
Jayewardene, A
Stone, J
Gambertoglio, JG
Aweeka, FT
Citation: Jd. Chi et al., A direct determination of thymidine triphosphate concentrations without dephosphorylation in peripheral blood mononuclear cells by LC/MS/MS, J PHARM B, 26(5-6), 2001, pp. 829-836
Authors:
Jayewardene, AL
Kearney, B
Stone, JA
Gambertoglio, JG
Aweeka, FT
Citation: Al. Jayewardene et al., An LC-MS-MS method for the determination of indinavir, an HIV-1 protease inhibitor, in human plasma, J PHARM B, 25(2), 2001, pp. 309-317
Citation: Sm. Tsunoda et Ft. Aweeka, Drug concentration monitoring of immunosuppressive agents - Focus on tacrolimus, mycophenolate mofetil and sirolimus, BIODRUGS, 14(6), 2000, pp. 355-369
Authors:
Homma, M
Beckerman, K
Hayashi, S
Jayewardene, AL
Oka, K
Gambertoglio, JG
Aweeka, FT
Citation: M. Homma et al., Liquid chromatographic determination of urinary 6 beta-hydroxycortisol to assess cytochrome p-450 3A activity in HIV positive pregnant women, J PHARM B, 23(4), 2000, pp. 629-635
Authors:
Aweeka, FT
Jacobson, MA
Martin-Munley, S
Hedman, A
Schoenfeld, P
Omachi, R
Tsunoda, S
Gambertoglio, JG
Citation: Ft. Aweeka et al., Effect of renal disease and hemodialysis on foscarnet pharmacokinetics anddosing recommendations, J ACQ IMM D, 20(4), 1999, pp. 350-357
Authors:
Brody, SR
Humphreys, MH
Gambertoglio, JG
Schoenfeld, P
Cundy, KC
Aweeka, FT
Citation: Sr. Brody et al., Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis, CLIN PHARM, 65(1), 1999, pp. 21-28